Nov 03, 2016 3:31pm EDT OPKO to Announce Third Quarter Operating and Financial Results on November 7, 2016
Sep 13, 2016 8:30am EDT OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories
Sep 06, 2016 8:30am EDT OPKO to Present Long-acting Human Growth Hormone (hGH-CTP) Phase 2 Pediatric Growth Hormone Deficiency Data at the 55th Annual Meeting of the European Society for Paediatric Endocrinology